EICHORCondition: Intrapartum - Moderate and Severe Anaemia · Sponsor: London School of Hygiene and Tropical Medicine
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Postpartum haemorrhage (PPH) is responsible for about 100,000 maternal deaths every year, almost all of which occur in low and middle income countries. When given within three hours of birth, tranexamic acid reduces deaths due to bleeding in women with PPH by almost one third. However, for many women, treatment of PPH is too late to prevent death and severe morbidities. Over one-third of pregnant women in the world are anaemic and many are severely anaemic. We now want to do the WOMAN-2 trial to see if giving tranexamic acid can prevent PPH and other severe outcomes in women with moderate and severe anaemia.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Women with moderate or severe anaemia (haemoglobin level \<100 g/L or packed cell volume \<30%) after giving birth vaginally where the responsible clinician is substantially uncertain whether to use TXA Exclusion Criteria: * Women who are not legally adult (\<18 years) and not accompanied by a guardian * Women with a known allergy to tranexamic acid or its excipients * Women who experience postpartum haemorrhage before the umbilical cord is cut or clamped.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Mother & Child Hospital | Akure, Nigeria | — |
| University of Medical Sciences Teaching Hospital | Akure, Nigeria | — |
| Adeoyo Maternity Hospital | Ibadan, Nigeria | — |
| Ilorin General Hospital | Ilorin, Nigeria | — |
| Muhammad Abdullahi Wase Specialist Hospital | Kano, Nigeria | — |
| Ladoke Akintola University of Technology Teaching Hospital | Ogbomoso, Nigeria | — |
| State Hospital | Oyo, Nigeria | — |
| Ayub Teaching Hospital (Unit A) | Abbottabad, Pakistan | — |
| Ayub Teaching Hospital (Unit C) | Abbottabad, Pakistan | — |
| Ayub Teaching Hospital Unit B | Abbottabad, Pakistan | — |
| Bahawalpur Victoria Hospital | Bahawalpur, Pakistan | — |
| Aziz Bhatti Teaching Hospital | Gujrat, Pakistan | — |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03475342